Association of Neutrophil-Lymphocyte Ratio With the Presence and Severity of Rheumatic Mitral Valve Stenosis
dc.contributor.author | Polat, Nihat | |
dc.contributor.author | Yildiz, Abdulkadir | |
dc.contributor.author | Yuksel, Murat | |
dc.contributor.author | Bilik, Mehmet Zihni | |
dc.contributor.author | Aydin, Mesut | |
dc.contributor.author | Acet, Halit | |
dc.contributor.author | Akil, Mehmet Ata | |
dc.date.accessioned | 2024-04-24T17:14:39Z | |
dc.date.available | 2024-04-24T17:14:39Z | |
dc.date.issued | 2014 | |
dc.department | Dicle Üniversitesi | en_US |
dc.description.abstract | The aim of the study is to investigate the association between the severity of rheumatic mitral valvular disease (RMVD) and the neutrophil-lymphocyte ratio (NLR). A total of 227 patients were enrolled in the study and divided into 3 groups. Patients in group 1 had rheumatic mitral stenosis (RMS), those in group 2 had RMVD without stenosis, and those in group 3 served as the control group. Group 1 was further divided into 2 groups, severe mitral stenosis (MS) and mild to moderate MS. The NLR was significantly higher in patients with severe MS when compared to those with mild to moderate MS (P = .002) while lymphocyte count was lower (P = .034). Using a cutoff level of 2.56, the NLR predicted severe RMS with a sensitivity of 75% and specificity of 74%. In conclusion, as an inexpensive, simple, and accessible marker of inflammation, the NLR may be useful in predicting the presence and severity of MS in patients with RMVD. | en_US |
dc.description.sponsorship | Dicle University DUBAP | en_US |
dc.description.sponsorship | We are grateful to Dicle University DUBAP for their sponsorship about English editing of this manuscript. | en_US |
dc.identifier.doi | 10.1177/1076029613514131 | |
dc.identifier.endpage | 798 | en_US |
dc.identifier.issn | 1076-0296 | |
dc.identifier.issn | 1938-2723 | |
dc.identifier.issue | 8 | en_US |
dc.identifier.pmid | 24335245 | |
dc.identifier.scopus | 2-s2.0-84921032256 | |
dc.identifier.scopusquality | Q2 | |
dc.identifier.startpage | 793 | en_US |
dc.identifier.uri | https://doi.org/10.1177/1076029613514131 | |
dc.identifier.uri | https://hdl.handle.net/11468/18119 | |
dc.identifier.volume | 20 | en_US |
dc.identifier.wos | WOS:000343775700005 | |
dc.identifier.wosquality | Q3 | |
dc.indekslendigikaynak | Web of Science | |
dc.indekslendigikaynak | Scopus | |
dc.indekslendigikaynak | PubMed | |
dc.language.iso | en | en_US |
dc.publisher | Sage Publications Inc | en_US |
dc.relation.ispartof | Clinical and Applied Thrombosis-Hemostasis | |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | Rheumatic Valve Disease | en_US |
dc.subject | Mitral Stenosis | en_US |
dc.subject | Neutrophil To Lymphocyte Ratio | en_US |
dc.subject | Inflammation | en_US |
dc.title | Association of Neutrophil-Lymphocyte Ratio With the Presence and Severity of Rheumatic Mitral Valve Stenosis | en_US |
dc.title | Association of Neutrophil-Lymphocyte Ratio With the Presence and Severity of Rheumatic Mitral Valve Stenosis | |
dc.type | Article | en_US |